Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasm Metastasis × orteronel × Clear all

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Neoplasm Metastasis 1

Interventions

pembrolizumab 79 Gemcitabine 60 Paclitaxel 47 Docetaxel 45 Carboplatin 40 Nivolumab 32 Cisplatin 31 Capecitabine 30 Pemetrexed 29 Fluorouracil 27 Bevacizumab 27 Cetuximab 26 Trastuzumab 23 130-nm albumin-bound paclitaxel 23 Irinotecan 21 Albumin-Bound Paclitaxel 21 Fulvestrant 18 Panitumumab 16 Leucovorin 16 Oxaliplatin 14 abemaciclib 13 Ipilimumab 12 atezolizumab 11 Letrozole 11 Drug Therapy 11 vandetanib 10 palbociclib 10 exemestane 10 cemiplimab 10 Prednisone 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00569153 2016-04-04

TAK-700

Millennium Pharmaceuticals, Inc.

Phase 1/2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡